Open access peer-reviewed Edited Volume

Translational Research in Cancer

Edited by Sivapatham Sundaresan

SRM Institute of Science and Technology


Yeun-Hwa Gu

Junshin Gakuen University

Translational research in oncology benefits from an abundance of knowledge resulting from genome-scale studies concerning the molecular pathways involved in tumorigenesis. Translational oncology represents a bridge between basic research and clinical practice in cancer medicine. The vast majority of cancer cases are due to environmental risk factors. Many of these environmental factors are controllable lifestyle choices. Experimental cancer treatments are studied in clinical trials to compare the proposed treatment to the best existing treatment through translational research. The key features of the book include: 1) New screening for the development of radioprotectors: radioprotection and anti-cancer effect of β-Glucan (Enterococcus faecalis) 2) Translational perspective on hepatocellular carcinoma 3) Brachytherapy for endometrial cancer 4) Discovery of small molecule inhibitors for histone methyltransferases in cancer

Read more >Order hardcopy
Translational Research in CancerEdited by Sivapatham Sundaresan

Published: February 3rd 2021

DOI: 10.5772/intechopen.73772

ISBN: 978-1-83880-535-7

Print ISBN: 978-1-83880-534-0

eBook (PDF) ISBN: 978-1-78984-837-3

Copyright year: 2021

Books open for chapter submissions

2979 Total Chapter Downloads

2 Dimensions Citations


Open access peer-reviewed

1. Discovery of Small Molecule Inhibitors for Histone Methyltransferases in Cancer

By Aishat A. Motolani, Mengyao Sun, Matthew Martin, Steven Sun and Tao Lu


Open access peer-reviewed

2. IL10 as Cancer Biomarker

By Maria Teresa Gonzalez-Garza, Delia Elva Cruz-Vega and Carmen Maldonado-Bernal


Open access peer-reviewed

3. Ion Channels and Transporters as Cancer Biomarkers and Targets for Diagnostics with Antibodies

By Jessica Iorio, Claudia Duranti and Elena Lastraioli


Open access peer-reviewed

4. Translational Perspective in Hepatocellular Carcinoma

By Sivapatham Sundaresan and Palanirasu Rajapriya


Open access peer-reviewed

5. Chalcones: Potential Anticancer Agents

By Adam McCluskey and Cecilia Russell


Open access peer-reviewed

6. New Screening for the Development of Radioprotectors: Radioprotection and Anti-Cancer Effect of β-Glucan (Enterococcus faecalis)

By Yeun-Hwa Gu


Open access peer-reviewed

7. Evaluation by Monte Carlo Simulation of Doses Distribution in Tumors with Hypoxia

By Mirko Salomón Alva-Sánchez and Thatiane Alves Pianoschi


Open access peer-reviewed

8. Bozepinib: A Promising Selective Derivative Targeting Breast Cancer Stem Cells

By Joaquín M. Campos, Ana Conejo-García and Olga Cruz-López


Open access peer-reviewed

9. NQO1-Bioactivatable Therapeutics as Radiosensitizers for Cancer Treatment

By Naveen Singh, Edward A. Motea, Xiumei Huang, Colton L. Starcher, Jayne Silver, I-Ju Yeh, S. Louise Pay, Xiaolin Su, Kristen A. Russ, David A. Boothman and Erik A. Bey


Open access peer-reviewed

10. Brachytherapy in Endometrial Cancer

By Mehmet Sait Bakir


Open access peer-reviewed

11. Acquisition and Management of Data for Translational Science in Oncology

By Thomas J. FitzGerald, Maryann Bishop-Jodoin, Fran Laurie, Richard Hanusik, Matthew Iandoli, Kathryn Karolczuk, Sandra Kessel, Fred Prior, Joel Saltz, Ashish Sharma, Michael Knopp, Mark Rosen, Ying Xiao, David Followill, Jeff Michalski, Ameer Elaimy, James Shen, Peter Lee, Maria Giulia Cicchetti and Janaki Moni


Open access peer-reviewed

12. Implications of Radiosensitizer and Radioprotector Factors in Refining the Dose-Volume Constraints and Radiobiological Models

By Camil Ciprian Mirestean, Călin Gheorghe Buzea, Roxana Irina Iancu and Dragoș Petru Teodor Iancu


Edited Volume and chapters are indexed in

  • Worldcat
  • OpenAIRE
  • Google Scholar
  • AZ ebsco
  • Base
  • CNKI

Order a hardcopy of the Edited Volume

Free shipping with DHL Express

Hardcover (ex. VAT)£119

Order now

Residents of European Union countries need to add a Book Value-Added Tax Rate based on their country of residence. Institutions and companies, registered as VAT taxable entities in their own EU member state, will not pay VAT by providing IntechOpen with their VAT registration number. This is made possible by the EU reverse charge method.

Special discount for IntechOpen contributors

All IntechOpen contributors are offered special discounts starting at 40% OFF available through your personal dashboard

Login and purchase